{"id":3288,"date":"2014-01-03T22:42:14","date_gmt":"2014-01-03T22:42:14","guid":{"rendered":"http:\/\/totaltheme.wpengine.com\/base\/?page_id=2897"},"modified":"2023-03-09T20:56:44","modified_gmt":"2023-03-09T20:56:44","slug":"homepage-2","status":"publish","type":"page","link":"https:\/\/glycomantra.com\/sample\/","title":{"rendered":"Home"},"content":{"rendered":"
[vc_row][vc_column][vc_column_text][\/vc_column_text][layerslider_vc id=”1″][\/vc_column][\/vc_row][vc_row bg_color=”#f6f6f6″ bg_style=”stretch” border_color=”#4895c0″ border_style=”solid” border_width=”0px 0px 0px 5px” padding_top=”30px” padding_bottom=”30px” padding_left=”30px” padding_right=”30px” margin_top=”45px” margin_bottom=”15px”][vc_column width=”3\/4″][vc_column_text]GlycoMantra is a biologics company developing novel therapeutics for unmet medical needs in metastatic castration-resistant prostate cancer, NASH liver fibrosis, and type 2 diabetes.\u00a0<\/span>[\/vc_column_text][\/vc_column][vc_column width=”1\/4″]Contact Us<\/span><\/a> [\/vc_column][\/vc_row][vc_row bg_style=”stretch” border_style=”solid” margin_top=”40px” margin_bottom=”35px”][vc_column width=”1\/2″][vc_accordion][vc_accordion_tab title=”Product Pipeline”][vc_column_text]Galectin-3 is involved in cancer progression and metastasis of many solid tumors not only by mediating\u00a0neo-angiogenesis and cancer cell homotypic\/heterotypic adhesions, but also by suppressing host immunity. Click here to learn more…<\/span><\/a>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=”Our Research”][vc_column_text]Current focus of our research is on the galectin-3, a member of the beta-galactoside-binding lectin family. Click here to learn more…<\/span><\/a>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=”Our Team”][vc_column_text]Our experienced and dedicated team is ready to provide wide range of research services from simple one step protein or antibody purification…Click here to learn more about our team…<\/span><\/a>[\/vc_column_text][\/vc_accordion_tab][\/vc_accordion][\/vc_column][vc_column width=”1\/2″][vc_column_text]\n

Who We Are\/Our Interest<\/span><\/h1>\n

We are a start-up biotechnology firm leading the translational glycobiology research and interested in the development of carbohydrate-based therapeutics of cancer, fibrosis, and diabetes. Animal cell surfaces are covered with carbohydrates and proteins. In normal scenario, these components mediate interactions between two cells or between the cell and the extra-cellular matrix components. However, abnormal protein-carbohydrate interactions and associated cell signaling can lead to many diseases such as cancer, fibrosis, and diabetes. Our goal is to develop high affinity carbohydrate-based drugs that counteract these abnormal interactions[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]\n<\/section>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_column_text][\/vc_column_text][layerslider_vc id=”1″][\/vc_column][\/vc_row][vc_row bg_color=”#f6f6f6″ bg_style=”stretch” border_color=”#4895c0″ border_style=”solid” border_width=”0px 0px 0px 5px” padding_top=”30px” padding_bottom=”30px” padding_left=”30px” padding_right=”30px” margin_top=”45px” margin_bottom=”15px”][vc_column width=”3\/4″][vc_column_text]GlycoMantra is a biologics company developing novel therapeutics for unmet medical needs in metastatic castration-resistant prostate cancer, NASH liver fibrosis, and type 2 diabetes.\u00a0[\/vc_column_text][\/vc_column][vc_column width=”1\/4″][\/vc_column][\/vc_row][vc_row bg_style=”stretch” border_style=”solid” margin_top=”40px” margin_bottom=”35px”][vc_column width=”1\/2″][vc_accordion][vc_accordion_tab title=”Product Pipeline”][vc_column_text]Galectin-3 is involved in cancer progression and metastasis…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"footnotes":""},"yoast_head":"\nHome - https:\/\/glycomantra.com\/sample<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/glycomantra.com\/sample\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Home - https:\/\/glycomantra.com\/sample\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text][\/vc_column_text][layerslider_vc id=”1″][\/vc_column][\/vc_row][vc_row bg_color=”#f6f6f6″ bg_style=”stretch” border_color=”#4895c0″ border_style=”solid” border_width=”0px 0px 0px 5px” padding_top=”30px” padding_bottom=”30px” padding_left=”30px” padding_right=”30px” margin_top=”45px” margin_bottom=”15px”][vc_column width=”3\/4″][vc_column_text]GlycoMantra is a biologics company developing novel therapeutics for unmet medical needs in metastatic castration-resistant prostate cancer, NASH liver fibrosis, and type 2 diabetes.\u00a0[\/vc_column_text][\/vc_column][vc_column width=”1\/4″][\/vc_column][\/vc_row][vc_row bg_style=”stretch” border_style=”solid” margin_top=”40px” margin_bottom=”35px”][vc_column width=”1\/2″][vc_accordion][vc_accordion_tab title=”Product Pipeline”][vc_column_text]Galectin-3 is involved in cancer progression and metastasis…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/glycomantra.com\/sample\/\" \/>\n<meta property=\"og:site_name\" content=\"https:\/\/glycomantra.com\/sample\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-09T20:56:44+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/glycomantra.com\/sample\/\",\"url\":\"https:\/\/glycomantra.com\/sample\/\",\"name\":\"Home - https:\/\/glycomantra.com\/sample\",\"isPartOf\":{\"@id\":\"https:\/\/glycomantra.com\/sample\/#website\"},\"datePublished\":\"2014-01-03T22:42:14+00:00\",\"dateModified\":\"2023-03-09T20:56:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/glycomantra.com\/sample\/#breadcrumb\"},\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/glycomantra.com\/sample\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/glycomantra.com\/sample\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/glycomantra.com\/sample\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/glycomantra.com\/sample\/#website\",\"url\":\"https:\/\/glycomantra.com\/sample\/\",\"name\":\"https:\/\/glycomantra.com\/sample\",\"description\":\"Glycomantra\",\"publisher\":{\"@id\":\"https:\/\/glycomantra.com\/sample\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/glycomantra.com\/sample\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/glycomantra.com\/sample\/#organization\",\"name\":\"Glycomantra\",\"url\":\"https:\/\/glycomantra.com\/sample\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en\",\"@id\":\"https:\/\/glycomantra.com\/sample\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/www.glycorx.com\/wp-content\/uploads\/2014\/03\/final-logo-72.png\",\"contentUrl\":\"http:\/\/www.glycorx.com\/wp-content\/uploads\/2014\/03\/final-logo-72.png\",\"width\":72,\"height\":72,\"caption\":\"Glycomantra\"},\"image\":{\"@id\":\"https:\/\/glycomantra.com\/sample\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Home - https:\/\/glycomantra.com\/sample","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/glycomantra.com\/sample\/","og_locale":"en_US","og_type":"article","og_title":"Home - https:\/\/glycomantra.com\/sample","og_description":"[vc_row][vc_column][vc_column_text][\/vc_column_text][layerslider_vc id=”1″][\/vc_column][\/vc_row][vc_row bg_color=”#f6f6f6″ bg_style=”stretch” border_color=”#4895c0″ border_style=”solid” border_width=”0px 0px 0px 5px” padding_top=”30px” padding_bottom=”30px” padding_left=”30px” padding_right=”30px” margin_top=”45px” margin_bottom=”15px”][vc_column width=”3\/4″][vc_column_text]GlycoMantra is a biologics company developing novel therapeutics for unmet medical needs in metastatic castration-resistant prostate cancer, NASH liver fibrosis, and type 2 diabetes.\u00a0[\/vc_column_text][\/vc_column][vc_column width=”1\/4″][\/vc_column][\/vc_row][vc_row bg_style=”stretch” border_style=”solid” margin_top=”40px” margin_bottom=”35px”][vc_column width=”1\/2″][vc_accordion][vc_accordion_tab title=”Product Pipeline”][vc_column_text]Galectin-3 is involved in cancer progression and metastasis…","og_url":"https:\/\/glycomantra.com\/sample\/","og_site_name":"https:\/\/glycomantra.com\/sample","article_modified_time":"2023-03-09T20:56:44+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/glycomantra.com\/sample\/","url":"https:\/\/glycomantra.com\/sample\/","name":"Home - https:\/\/glycomantra.com\/sample","isPartOf":{"@id":"https:\/\/glycomantra.com\/sample\/#website"},"datePublished":"2014-01-03T22:42:14+00:00","dateModified":"2023-03-09T20:56:44+00:00","breadcrumb":{"@id":"https:\/\/glycomantra.com\/sample\/#breadcrumb"},"inLanguage":"en","potentialAction":[{"@type":"ReadAction","target":["https:\/\/glycomantra.com\/sample\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/glycomantra.com\/sample\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/glycomantra.com\/sample\/"},{"@type":"ListItem","position":2,"name":"Home"}]},{"@type":"WebSite","@id":"https:\/\/glycomantra.com\/sample\/#website","url":"https:\/\/glycomantra.com\/sample\/","name":"https:\/\/glycomantra.com\/sample","description":"Glycomantra","publisher":{"@id":"https:\/\/glycomantra.com\/sample\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/glycomantra.com\/sample\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en"},{"@type":"Organization","@id":"https:\/\/glycomantra.com\/sample\/#organization","name":"Glycomantra","url":"https:\/\/glycomantra.com\/sample\/","logo":{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/glycomantra.com\/sample\/#\/schema\/logo\/image\/","url":"http:\/\/www.glycorx.com\/wp-content\/uploads\/2014\/03\/final-logo-72.png","contentUrl":"http:\/\/www.glycorx.com\/wp-content\/uploads\/2014\/03\/final-logo-72.png","width":72,"height":72,"caption":"Glycomantra"},"image":{"@id":"https:\/\/glycomantra.com\/sample\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/glycomantra.com\/sample\/wp-json\/wp\/v2\/pages\/3288"}],"collection":[{"href":"https:\/\/glycomantra.com\/sample\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/glycomantra.com\/sample\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/glycomantra.com\/sample\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/glycomantra.com\/sample\/wp-json\/wp\/v2\/comments?post=3288"}],"version-history":[{"count":51,"href":"https:\/\/glycomantra.com\/sample\/wp-json\/wp\/v2\/pages\/3288\/revisions"}],"predecessor-version":[{"id":4165,"href":"https:\/\/glycomantra.com\/sample\/wp-json\/wp\/v2\/pages\/3288\/revisions\/4165"}],"wp:attachment":[{"href":"https:\/\/glycomantra.com\/sample\/wp-json\/wp\/v2\/media?parent=3288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}